UK Abuzz With Action On Clinical Trial Transparency
Parliamentary Panel Hearing, New Transparency Strategy In The Works
Executive Summary
In the run-up to a hearing by a UK parliamentary committee on clinical trial transparency, a new report highlights continued non-compliance by some non-commercial sponsors. Concerns have also been raised about the effect of introducing sanctions.
You may also be interested in...
UK Panel Urged To Keep Trial Transparency In The Spotlight
The recent momentum gained in the UK towards furthering clinical trial transparency needs to be kept up, say advocacy groups.
UK Heads For Full Trial Transparency
The UK’s Health Research Authority has agreed in principle to implement a new policy that aims to drive a lasting change in clinical trial transparency. Not everyone is convinced.
UK Seeks To Make Clinical Trial Transparency 'Second Nature' For Sponsors
The UK's Health Research Authority says there is no one reason why registration of clinical trials and reporting of results continue to fall short of requirements. It has issued proposals to bring about significant improvements.